DCM
DAWN

Driehaus Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Driehaus Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-526,732
Closed -$7.34M – 407
2024
Q3 		$7.34M Sell
526,732
-179,714
-25% -$2.56M 0.06% 253
2024
Q2 		$9.73M Sell
706,446
-12,565
-2% -$184K 0.09% 221
2024
Q1 		$11.9M Buy
719,011
+235,772
+49% +$3.53M 0.12% 223
2023
Q4 		$7.06M Sell
483,239
-5,079
-1% -$61.6K 0.09% 255
2023
Q3 		$5.99M Buy
488,318
+10,212
+2% +$133K 0.08% 272
2023
Q2 		$5.71M Buy
478,106
+6,222
+1% +$81.3K 0.07% 266
2023
Q1 		$6.31M Sell
471,884
-11,600
-2% -$227K 0.09% 276
2022
Q4 		$10.4M Sell
483,484
-6,488
-1% -$133K 0.16% 199
2022
Q3 		$9.81M Sell
489,972
-11,717
-2% -$249K 0.15% 194
2022
Q2 		$8.98M Buy
501,689
+98,231
+24% +$1.01M 0.15% 212
2022
Q1 		$4M Sell
403,458
-7,749
-2% -$102K 0.05% 309
2021
Q4 		$6.93M Sell
411,207
-20,239
-5% -$416K 0.07% 268
2021
Q3 		$10.2M Sell
431,446
-2,977
-0.7% -$71.3K 0.12% 230
2021
Q2 		$9.89M Buy
+434,423
New +$9.06M 0.13% 227

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ECM
Estuary Capital Management Wayzata, Minnesota $598M AUM 1.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Driehaus Capital Management's DAWN Position: Q4 2024 in Review

Driehaus Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q4 2024, closing a stake of 526,732 shares — an estimated $7.34M sold.

Driehaus Capital Management first reported a position in DAWN in Q2 2021 and held it in 14 quarters. The position peaked at $11.9M in Q1 2024. 164 funds tracked by Wall St. Rank hold DAWN as of Q4 2024.

  • Driehaus Capital Management reported no remaining Day One Biopharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 526,732 Day One Biopharmaceuticals shares in Q4 2024, an estimated $7.34M.
  • Driehaus Capital Management first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 14 quarters.
  • Driehaus Capital Management's Day One Biopharmaceuticals position peaked at $11.9M in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2024.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.